Ménage à trois: Aldosterone, sodium and nitric oxide in vascular endothelium

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1802, Issue 12, 2010, Pages 1193-1202

  Fels, Johannes ^a   Oberleithner, Hans ^a   Kusche Vihrog, Kristina ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Aldosterone; ENaC; Endothelia; Nitric oxide; Sodium

Indexed keywords

ALDOSTERONE; NITRIC OXIDE; POTASSIUM; SODIUM; SODIUM CHANNEL;

CELL MEMBRANE; ENDOTHELIUM CELL; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; VASCULAR ENDOTHELIUM;

ALDOSTERONE; ANIMALS; BLOOD PRESSURE; CELL MEMBRANE; CELL SIZE; ENDOTHELIUM, VASCULAR; FIBROSIS; HUMANS; NITRIC OXIDE; POTASSIUM; SODIUM; WATER-ELECTROLYTE BALANCE;

EID: 77957894160     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2010.03.006     Document Type: Review

References (100)

1. Rossier B.C., Palmer L.G. Mechanisms of aldosterone action on sodium and potassium transport. The Kidney: Physiology and Pathophysiology 1992, 1373-1409. Raven Press, New York. D.W. Seldin, G. Giebisch (Eds.).
2. Gekle M., Golenhofen N., Oberleithner H., Silbernagl S. Rapid activation of Na+/H+exchange by aldosterone in renal epithelial cells requires Ca2+ and stimulation of a plasma membrane proton conductance. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:10500-10504.
3. Oberleithner H., Weigt M., Westphale H.J., Wang W. Aldosterone activates Na+/H+exchange and raises cytoplasmic pH in target cells of the amphibian kidney. Proc. Natl. Acad. Sci. U. S. A. 1987, 84:1464-1468.
4. Gorelik J., Zhang Y., Sanchez D., Shevchuk A., Frolenkov G., Lab M., Klenerman D., Edwards C., Korchev Y. Aldosterone acts via an ATP autocrine/paracrine system: the Edelman ATP hypothesis revisited. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:15000-15005.
5. Safar M.E. Systolic hypertension in the elderly: arterial wall mechanical properties and the renin-angiotensin-aldosterone system. J. Hypertens. 2005, 23:673-681.
6. Brilla C.G., Weber K.T. Mineralocorticoid excess, dietary sodium, and myocardial fibrosis. J. Lab. Clin. Med. 1992, 120:893-901.
7. Funder J.W. Mineralocorticoid receptors and cardiovascular damage: it's not just aldosterone. Hypertension 2006, 47:634-635.
8. Fritsch N.M., Schiffrin E.L. Aldosterone: a risk factor for vascular disease. Curr. Hypertens. Rep. 2003, 5:59-65.
9. Hashikabe Y., Suzuki K., Jojima T., Uchida K., Hattori Y. Aldosterone impairs vascular endothelial cell function. J. Cardiovasc. Pharmacol. 2006, 47:609-613.
10. Schiffrin E.L. Effects of aldosterone on the vasculature. Hypertension 2006, 47:312-318.
11. Oberleithner H., Ludwig T., Riethmüller C., Hillebrand U., Albermann L., Schäfer C., Shahin V., Schillers H. Human endothelium: target for aldosterone. Hypertension 2004, 43:1-5.
12. Golestaneh N., Klein C., Valamanesh F., Suarez G., Agarwal M.K., Mirshahi M. Mineralocorticoid receptor-mediated signaling regulates the ion gated sodium channel in vascular endothelial cells and requires an intact cytoskeleton. Biochem. Biophys. Res. Commun. 2001, 280:1300-1306.
13. Chen W., Valamanesh F., Mirshahi T., Soria J., Tang R., Agarwal M.K., Mirshahi M. Aldosterone signaling modifies capillary formation by human bone marrow endothelial cells. Vasc. Pharmacol. 2004, 40(6):269-277.
14. Oberleithner H., Riethmüller C., Ludwig T., Shahin V., Stock C., Schwab A., Hausberg M., Kusche K., Schillers H. Differential action of steroid hormones on human endothelium. J. Cell Sci. 2006, 119:1926-1932.
15. Oberleithner H. Unorthodox sites and modes of aldosterone action. NIPS 2004, 19:51-54.
16. Oberleithner H. Aldosterone makes human endothelium stiff and vulnerable. Kidney Int. 2005, 67:1680-1682.
17. + exchange. Cardiovasc. Res. 2006, 69:916-924.
18. Pesen D., Hoh J.H. Micromechanical architecture of the endothelial cell cortex. Biophys. J. 2005, 88:670-679.
19. Cross S.E., Jin Y.S., Rao J., Gimzewski J.K. Nanomechanical analysis of cells from cancer patients. Nat. Nanotechnol. 2007, 2:780-783.
20. Hsieh C.H., Lin Y.H., Lin S., Tsai-Wu J.J., Herbert Wu C.H., Jiang C.C. Surface ultrastructure and mechanical property of human chondrocyte revealed by atomic force microscopy. Osteoarthritis Cartilage 2008, 16:480-488.
21. Fairbank N.J., Connolly S.C., Mackinnon J.D., Wehry K., Deng L., Maksym G.N. Airway smooth muscle cell tone amplifies contractile function in the presence of chronic cyclic strain. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008, 295:L479-L488.
22. Varma N., Eberli F.R., Apstein C.S. Left ventricular diastolic dysfunction during demand ischemia: rigor underlies increased stiffness without calcium-mediated tension. Amelioration by glycolytic substrate. J. Am. Coll. Cardiol. 2001, 37:2144-2153.
23. Oberleithner H., Riethmuller C., Ludwig T., Hausberg M., Schillers H. Aldosterone remodels human endothelium. Acta. Physiol. (Oxf.) 2006, 187:305-312.
24. Oberleithner H., Riethmuller C., Schillers H., MacGregor G.A., de Wardener H.E., Hausberg M. Plasma sodium stiffens vascular endothelium and reduces nitric oxide release. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:16281-16286.
25. Oberleithner H., Callies C., Kusche-Vihrog K., Schillers H., Shahin V., Riethmuller C., MacGregor G.A., de Wardener H.E. Potassium softens vascular endothelium and increases nitric oxide release. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:2829-2834.
26. Oberleithner H., Schneider S.W., Albermann L., Hillebrand U., Ludwig T., Riethmüller C., Shahin V., Schäfer C., Schillers H. Endothelial cell swelling by aldosterone. J. Membr. Biol. 2003, 196:163-172.
27. Oberleithner H. Is the vascular endothelium under the control of aldosterone? Facts and hypothesis. Pflugers Arch. 2007, 454:187-193.
28. Nishizaka M.K., Zaman M.A., Green S.A., Renfroe K.Y., Calhoun D.A. Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism. Circulation 2004, 109:2857-2861.
29. Nagata D., Takahashi M., Sawai K., Tagami T., Usui T., Shimatsu A., Hirata Y., Naruse M. Molecular mechanism of the inhibitory effect of aldosterone on endothelial NO synthase activity. Hypertension 2006, 48:165-171.
30. Shimoda L.A., Norins N.A., Madden J.A. Responses to pulsatile flow in piglet isolated cerebral arteries. Pediatr. Res. 1998, 43:514-520.
31. Schneider M., Ulsenheimer A., Christ M., Wehling M. Nongenomic effects of aldosterone on intracellular calcium in porcine endothelial cells. Am. J. Physiol. 1997, 272:E616-E620.
32. Maguire D., MacNamara B., Cuffe J.E., Winter D., Doolan C.M., Urbach V., O'Sullivan G.C., Harvey B.J. Rapid responses to aldosterone in human distal colon. Steroids 1999, 64:51-63.
33. Grossmann C., Benesic A., Krug A.W., Freudinger R., Mildenberger S., Gassner B., Gekle M. Human mineralocorticoid receptor expression renders cells responsive for nongenotropic aldosterone actions. Mol. Endocrinol. 2005, 19:1697-1710.
34. Schafer C., Shahin V., Albermann L., Hug M.J., Reinhardt J., Schillers H., Schneider S.W., Oberleithner H. Aldosterone signaling pathway across the nuclear envelope. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:7154-7159.
35. Williams T.A., Verhovez A., Milan A., Veglio F., Mulatero P. Protective effect of spironolactone on endothelial cell apoptosis. Endocrinology 2006, 147:2496-2505.
36. Beesley A.H., Hornby D., White S.J. Regulation of distal nephron K+channels (ROMK) mRNA expression by aldosterone in rat kidney. J. Physiol. 1998, 509(Pt 3):629-634.
37. Kolla V., Litwack G. Transcriptional regulation of the human Na/K ATPase via the human mineralocorticoid receptor. Mol. Cell. Biochem. 2000, 204:35-40.
38. Chen S.-Y., Bhargava A., Mastroberardino L., Meijer O.C., Wang J., Buse P., Firestone G.L., Verrey F., Pearce D. Epithelial sodium channel regulated by aldosterone-induced protein sgk. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:2514-2519.
39. Wehling M., Kasmayr J., Theisen K. Fast effects of aldosterone on electrolytes in human lymphocytes are mediated by the sodium-proton-exchanger of the cell membrane. Biochem. Biophys. Res. Commun. 1989, 164:961-967.
40. Moura A.M., Worcel M. Direct action of aldosterone on transmembrane 22Na efflux from arterial smooth muscle. Rapid and delayed effects. Hypertension 1984, 6:425-430.
41. Kusche-Vihrog K., Callies C., Fels J., Oberleithner H. The epithelial sodium channel (ENaC): mediator of the aldosterone response in the vascular endothelium?. Steroids 2010, 75:544-549.
42. + channel is made of three homologous subunits. Nature 1994, 367:463-467.
43. + channel. Am. J. Physiol. 1994, 266:L728-L734.
44. + channel. J. Biol. Chem. 1995, 270:27411-27414.
45. Bangel-Ruland N., Sobczak K., Christmann T., Kentrup D., Langhorst H., Kusche-Vihrog K., Weber W.M. Characterization of the epithelial sodium channel delta subunit in human nasal epithelium. Am. J. Respir. Cell Mol. Biol. 2010, 42:498-505.
46. Kleyman T.R., Carattino M.D., Hughey R.P. ENaC at the cutting edge: regulation of epithelial sodium channels by proteases. J. Biol. Chem. 2009, 284:20447-20451.
47. Lee I.H., Campbell C.R., Cook D.I., Dinudom A. Regulation of epithelial Na+channels by aldosterone: role of Sgk1. Clin. Exp. Pharmacol. Physiol. 2008, 35:235-241.
48. Alvarez de la Rosa D., Canessa C.M., Fyfe G.K., Zhang P. Structure and regulation of amiloride-sensitive sodium channels. Annu. Rev. Physiol. 2000, 62:573-594.
49. Wang S., Meng F., Mohan S., Champaneri B., Gu Y. Functional ENaC channels expressed in endothelial cells: a new candidate for mediating shear force. Microcirculation 2009, 16:276-287.
50. Kusche-Vihrog K., Sobczak K., Bangel N., Wilhelmi M., Nechyporuk-Zloy V., Schwab A., Schillers H., Oberleithner H. Aldosterone and amiloride alter ENaC abundance in vascular endothelium. Pflugers Arch. 2008, 455:849-857.
51. Zhou Z.H., Bubien J.K. Nongenomic regulation of ENaC by aldosterone. Am. J. Physiol. Cell Physiol. 2001, 281:C1118-C1130.
52. Harvey B.J., Alzamora R., Stubbs A.K., Irnaten M., McEneaney V., Thomas W. Rapid responses to aldosterone in the kidney and colon. J. Steroid Biochem. Mol. Biol. 2008, 108:310-317.
53. Grossmann C., Gekle M. New aspects of rapid aldosterone signaling. Mol. Cell. Endocrinol. 2009, 308:53-62.
54. McEneaney V., Harvey B.J., Thomas W. Aldosterone regulates rapid trafficking of epithelial sodium channel subunits in renal cortical collecting duct cells via protein kinase D activation. Mol. Endocrinol. 2008, 22:881-892.
55. Wildling L., Hinterdorfer P., Kusche-Vihrog K., Treffner Y., Oberleithner H. Aldosterone receptor sites on plasma membrane of human vascular endothelium detected by a mechanical nanosensor. Pflugers Arch. 2009, 458:223-230.
56. Cantiello H.F., Stow J.L., Prat A.G., Ausiello D.A. Actin filaments regulate epithelial Na channel activity. Am. J. Physiol. 1991, 261:C882-C888.
57. Mazzochi C., Bubien J.K., Smith P.R., Benos D.J. The carboxyl terminus of the alpha-subunit of the amiloride-sensitive epithelial sodium channel binds to F-actin. J. Biol. Chem. 2006, 281:6528-6538.
58. Titze J., Ritz E. Salt and its effect on blood pressure and target organ damage: new pieces in an old puzzle. J. Nephrol. 2009, 22:177-189.
59. Takeda Y. Vascular synthesis of aldosterone: role in hypertension. Mol. Cell. Endocrinol. 2004, 217:75-79.
60. Hakim T.S., Sugimori K., Camporesi E.M., Anderson G. Half-life of nitric oxide in aqueous solutions with and without haemoglobin. Physiol. Meas. 1996, 17:267-277.
61. Malinski T., Taha Z., Grunfeld S., Patton S., Kapturczak M., Tomboulian P. Diffusion of nitric oxide in the aorta wall monitored in situ by porphyrinic microsensors. Biochem. Biophys. Res. Commun. 1993, 193:1076-1082.
62. Fleming I., Busse R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 284:R1-R12.
63. Sessa W.C. Regulation of endothelial derived nitric oxide in health and disease. Mem. Inst. Oswaldo Cruz 2005, 100(Suppl 1):15-18.
64. Arima S., Kohagura K., Xu H.L., Sugawara A., Uruno A., Satoh F., Takeuchi K., Ito S. Endothelium-derived nitric oxide modulates vascular action of aldosterone in renal arteriole. Hypertension 2004, 43:352-357.
65. Michea L., Villagran A., Urzua A., Kuntsmann S., Venegas P., Carrasco L., Gonzalez M., Marusic E.T. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and prevents oxidative stress in uremic rats. Hypertension 2008, 52:295-300.
66. Wehling M., Ulsenheimer A., Schneider M., Neylon C., Christ M. Rapid effects of aldosterone on free intracellular calcium in vascular smooth muscle and endothelial cells: subcellular localization of calcium elevations by single cell imaging. Biochem. Biophys. Res. Commun. 1994, 204:475-481.
67. Mazak I., Fiebeler A., Muller D.N., Park J.K., Shagdarsuren E., Lindschau C., Dechend R., Viedt C., Pilz B., Haller H., Luft F.C. Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells. Circulation 2004, 109:2792-2800.
68. Gros R., Ding Q., Armstrong S., O'Neil C., Pickering J.G., Feldman R.D. Rapid effects of aldosterone on clonal human vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 2007, 292:C788-C794.
69. Heylen E., Huang A., Sun D., Kaley G. Nitric oxide-mediated dilation of arterioles to intraluminal administration of aldosterone. J. Cardiovasc. Pharmacol. 2009, 54:535-542.
70. Liu S.L., Schmuck S., Chorazcyzewski J.Z., Gros R., Feldman R.D. Aldosterone regulates vascular reactivity: short-term effects mediated by phosphatidylinositol 3-kinase-dependent nitric oxide synthase activation. Circulation 2003, 108:2400-2406.
71. Schmidt B.M., Oehmer S., Delles C., Bratke R., Schneider M.P., Klingbeil A., Fleischmann E.H., Schmieder R.E. Rapid nongenomic effects of aldosterone on human forearm vasculature. Hypertension 2003, 42:156-160.
72. + channel surface expression. EMBO J. 2001, 20:7052-7059.
73. Snyder P.M., Olson D.R., Thomas B.C. Serum and glucocorticoid-regulated kinase modulates Nedd4-2-mediated inhibition of the epithelial Na+channel. J. Biol. Chem. 2002, 277:5-8.
74. Kojima H., Nakatsubo N., Kikuchi K., Kawahara S., Kirino Y., Nagoshi H., Hirata Y., Nagano T. Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. Anal. Chem. 1998, 70:2446-2453.
75. Kojima H., Hirotani M., Nakatsubo N., Kikuchi K., Urano Y., Higuchi T., Hirata Y., Nagano T. Bioimaging of nitric oxide with fluorescent indicators based on the rhodamine chromophore. Anal. Chem. 2001, 73:1967-1973.
76. Mutoh A., Isshiki M., Fujita T. Aldosterone enhances ligand-stimulated nitric oxide production in endothelial cells. Hypertens. Res. 2008, 31:1811-1820.
77. Virdis A., Neves M.F., Amiri F., Viel E., Touyz R.M., Schiffrin E.L. Spironolactone improves angiotensin-induced vascular changes and oxidative stress. Hypertension 2002, 40:504-510.
78. Park Y.M., Park M.Y., Suh Y.L., Park J.B. NAD(P)H oxidase inhibitor prevents blood pressure elevation and cardiovascular hypertrophy in aldosterone-infused rats. Biochem. Biophys. Res. Commun. 2004, 313:812-817.
79. Farquharson C.A., Struthers A.D. Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure. Circulation 2000, 101:594-597.
80. Farquharson C.A., Struthers A.D. Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy. Clin. Sci. (Lond.) 2002, 103:425-431.
81. Kobayashi N., Yoshida K., Nakano S., Ohno T., Honda T., Tsubokou Y., Matsuoka H. Cardioprotective mechanisms of eplerenone on cardiac performance and remodeling in failing rat hearts. Hypertension 2006, 47:671-679.
82. Uhrenholt T.R., Schjerning J., Hansen P.B., Norregaard R., Jensen B.L., Sorensen G.L., Skott O. Rapid inhibition of vasoconstriction in renal afferent arterioles by aldosterone. Circ. Res. 2003, 93:1258-1266.
83. Kondrikov D., Han H.R., Block E.R., Su Y. Growth and density-dependent regulation of NO synthase by the actin cytoskeleton in pulmonary artery endothelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 290:L41-L50.
84. Kidoaki S., Matsuda T., Yoshikawa K. Relationship between apical membrane elasticity and stress fiber organization in fibroblasts analyzed by fluorescence and atomic force microscopy. Biomech. Model. Mechanobiol. 2006, 5:263-272.
85. Ushio-Fukai M. Vascular signaling through G protein-coupled receptors: new concepts. Curr. Opin. Nephrol. Hypertens. 2009, 18:153-159.
86. Rizzo M.A., Piston D.W. Regulation of beta cell glucokinase by S-nitrosylation and association with nitric oxide synthase. J. Cell Biol. 2003, 161:243-248.
87. Iwakiri Y., Satoh A., Chatterjee S., Toomre D.K., Chalouni C.M., Fulton D., Groszmann R.J., Shah V.H., Sessa W.C. Nitric oxide synthase generates nitric oxide locally to regulate compartmentalized protein S-nitrosylation and protein trafficking. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:19777-19782.
88. Huang B., Chen S.C., Wang D.L. Shear flow increases S-nitrosylation of proteins in endothelial cells. Cardiovasc. Res. 2009, 83:536-546.
89. Qian J., Zhang Q., Church J.E., Stepp D.W., Rudic R.D., Fulton D.J. The role of local production of endothelium-derived nitric oxide on cGMP signaling and S-nitrosylation. Am. J. Physiol. Heart Circ. Physiol. 2010, 298:H112-H118.
90. Zhang Q., Church J.E., Jagnandan D., Catravas J.D., Sessa W.C., Fulton D. Functional relevance of Golgi- and plasma membrane-localized endothelial NO synthase in reconstituted endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2006, 26:1015-1021.
91. Fulton D., Babbitt R., Zoellner S., Fontana J., Acevedo L., McCabe T.J., Iwakiri Y., Sessa W.C. Targeting of endothelial nitric-oxide synthase to the cytoplasmic face of the Golgi complex or plasma membrane regulates Akt- versus calcium-dependent mechanisms for nitric oxide release. J. Biol. Chem. 2004, 279:30349-30357.
92. Ibiza S., Perez-Rodriguez A., Ortega A., Martinez-Ruiz A., Barreiro O., Garcia-Dominguez C.A., Victor V.M., Esplugues J.V., Rojas J.M., Sanchez-Madrid F., Serrador J.M. Endothelial nitric oxide synthase regulates N-Ras activation on the Golgi complex of antigen-stimulated T cells. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:10507-10512.
93. Jin Z.G. Where is endothelial nitric oxide synthase more critical: plasma membrane or Golgi?. Arterioscler. Thromb. Vasc. Biol. 2006, 26:959-961.
94. Nietlispach F., Julius B., Schindler R., Bernheim A., Binkert C., Kiowski W., Brunner-La Rocca H.P. Influence of acute and chronic mineralocorticoid excess on endothelial function in healthy men. Hypertension 2007, 50:82-88.
95. Michea L., Delpiano A.M., Hitschfeld C., Lobos L., Lavandero S., Marusic E.T. Eplerenone blocks nongenomic effects of aldosterone on the Na+/H+exchanger, intracellular Ca2+ levels, and vasoconstriction in mesenteric resistance vessels. Endocrinology 2005, 146:973-980.
96. Romagni P., Rossi F., Guerrini L., Quirini C., Santiemma V. Aldosterone induces contraction of the resistance arteries in man. Atherosclerosis 2003, 166:345-349.
97. Gunaruwan P., Schmitt M., Sharman J., Lee L., Struthers A., Frenneaux M. Effects of aldosterone on forearm vasculature in treated chronic heart failure. Am. J. Cardiol. 2005, 95:412-414.
98. Schmidt B.M., Montealegre A., Janson C.P., Martin N., Stein-Kemmesies C., Scherhag A., Feuring M., Christ M., Wehling M. Short term cardiovascular effects of aldosterone in healthy male volunteers. J. Clin. Endocrinol. Metab. 1999, 84:3528-3533.
99. Gunaruwan P., Schmitt M., Taylor J., Lee L., Struthers A., Frenneaux M. Lack of rapid aldosterone effects on forearm resistance vasculature in health. J. Renin. Angiotensin. Aldosterone. Syst. 2002, 3:123-125.
100. Schmidt B.M., Sammer U., Fleischmann I., Schlaich M., Delles C., Schmieder R.E. Rapid nongenomic effects of aldosterone on the renal vasculature in humans. Hypertension 2006, 47:650-655.